Steroidal Regulation of Uterine Edema and Tissue Inhibitors of Metalloproteinase (TIMP)-3 Messenger RNA Expression is Altered in TIMP-1-Deficient Mice

Biology of Reproduction

Volumn 70, Issue 2, 2004, Pages 500-508

  Nothnick, Warren B ^a,b   Zhang, Xuan ^a   Zhou, Han E ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Estradiol; Female reproductive tract; Progesterone; Uterus

Indexed keywords

ESTRADIOL; FULVESTRANT; GENE PRODUCT; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE; STEROID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; MOUSE; MOUSE STRAIN; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS WEIGHT;

ANIMALS; EDEMA; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GENE EXPRESSION; MICE; MICE, MUTANT STRAINS; ORGAN SIZE; OVARIECTOMY; PROGESTERONE; PROTEINS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES; UTERUS;

ANIMALIA;

EID: 0742271482     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.103.020834     Document Type: Article

References (54)

1. Fazleabas AT, Strakova Z. Endometrial function: cell specific changes in the uterine environment. Mol Cell Endocrinol 2002; 186:143-147.
2. Tseng L, Mazella J. Endometrial cell specific gene activation during implantation and early pregnancy. Front Biosci 2002; 7:d1566-d1574.
3. Bagchi IC, Li Q, Cheon YP. Role of steroid-hormone-regulated genes in implantation. Ann N Y Acad Sci 2001; 943:68-76.
4. Lessey BA. Adhesion molecules and implantation. J Reprod Immunol 2002; 55:101-112.
5. Ma W, Tan J, Matsumoto H, Robert B, Abrahamson DR, Das SK, Dey SK. Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus. Mol Endocrinol 2001; 15:1983-1992.
6. Fazleabas AT, Bell SC, Fleming S, Sun J, Lessey BA. Distribution of integrins and the extracellular matrix proteins in the baboon endometrium during the menstrual cycle and early pregnancy. Biol Reprod 1997; 56:348-356.
7. Gray CA, Bartol FF, Tarleton BJ, Wiley AA, Johnson GA, Bazer FW, Spencer TE. Developmental biology of uterine glands. Biol Reprod 2001; 65:1311-1323.
8. Fata JE, Ho AT, Leco KJ, Moorehead RA, Khokha R. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 2000; 57:77-95.
9. Zhao YG, Xiao AZ, Cao XM, Zhu C. Expression of matrix metalloproteinase-2, -9 and tissue inhibitors of metalloproteinase-1, -2, -3 mRNAs in rat uterus during early pregnancy. Mol Reprod Dev 2002; 62:149-158.
10. Salamonsen LA, Nagase H, Woolley DE. Matrix metalloproteinases and their tissue inhibitors at the ovine trophoblast-uterine interface. J Reprod Fertil 1995; 49:29-37.
11. Bass KE, Li H, Hawkes SP, Howard E, Bullen E, Vu TK, McMaster M, Janatpour M, Fisher SJ. Tissue inhibitor of metalloproteinase-3 expression is upregulated during human cytotrophoblast invasion in vitro. Developmental Genetics 1997; 21:61-67.
12. Das SK, Yano S, Wang J, Edwards DR, Nagase H, Dey SK. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the periimplantation period. Developmental Genetics 1997; 21:44-54.
13. Harvey MB, Leco KJ, Arcellana-Panlilio MY, Zhang X, Edwards DR, Schultz GA. Proteinase expression in early mouse embryos is regulated by leukemia inhibitory factor and epidermal growth factor. Development 1995; 121:1005-1014.
14. Reponen P, Leivo I, Sahlberg C, Apte SS, Olsen BR, Thesleff I, Tryggvason K. 92-kDA type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev Dyn 1995; 202:388-396.
15. Waterhouse P, Denhardt DT, Khokha R, Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation. Mol Reprod Dev 1993; 35:219-226.
16. Menino AR Jr, Hogan A, Schultz GA, Novak S, Dixon W, Foxcroft GH. Expression of proteinases and proteinase inhibitors during embryo-uterine contact in the pig. Developmental Genetics 1997; 21:68-74.
17. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74:111-122.
18. Leco KJ, Apte SS, Taniguchi GT, Hawkes SP, Khokha R, Schultz GA, Edwards DR. Murine tissue inhibitor of metalloproteinase-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett 1997; 401:213-217.
19. Nothnick WB. Disruption of the tissue inhibitor of metalloproteinase-1 gene results in altered reproductive cyclicity and uterine morphology in reproductive-age female mice. Biol Reprod 2000; 63:905-912.
20. Hampton AL, Butt AR, Riley SC, Salamonsen LA. Tissue inhibitors of metalloproteinases in endometrium of ovariectomized steroid-treated ewes during the estrous cycle and early pregnancy. Biol Reprod 1995; 53:302-311.
21. Zhang J, Salamonsen LA. Tissue inhibitor of metalloproteinases (TIMP)-1, -2, and -3 in human endometrium during the menstrual cycle. Mol Hum Reprod 1997; 3:735-741.
22. Hampton AL, Salamonsen LA. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 1994; 141:R1-R3.
23. Higuchi T, Kanzaki H, Nakayama H, Fujimoto M, Hatayama H, Kojima K, Iwai M, Mori T, Fujita J. Induction of tissue inhibitor of metalloproteinase 3 gene expression during in vitro decidualization of human endometrial stromal cells. Endocrinology 1995; 136:4973-4981.
24. Rodgers W, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994; 94:946-953.
25. Brenner RM, Rudolph L, Matrisian L, Slayden OD. Non-human primate models: artificial menstrual cycles, endometrial matrix metalloproteinases and s.c. endometrial grafts. Hum Reprod 1996; 11:150-164.
26. Rudolph-Owen LA, Slayden OD, Matrisian LM, Brenner RM. Matrix metalloproteinase expression in Macaca mulatta endometrium: evidence for zone-specific regulatory tissue gradients. Biol Reprod 1998; 59:1349-1359.
27. Salamonsen LA, Butt AR, Hammond FR, Garcia S, Zhang J. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 1997; 82:1409-1415.
28. Nothnick WB. Reduction in reproductive lifespan of tissue inhibitor of metalloproteinase 1 (TIMP-1)-deficient female mice. Reproduction 2001; 122:923-927.
29. Nothnick WB. Disruption of the tissue inhibitor of metalloproteinase-1 gene in reproductive-age female mice is associated with estrous cycle stage-specific increases in stromelysin messenger RNA expression and activity. Biol Reprod 2001; 65:1780-1788.
30. Hampton AL, Nie G, Salamonsen LA. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects. Mol Hum Reprod 1999; 5:365-371.
31. Rosner B. Fundamentals of Biostatistics, 3rd ed. Boston: PWS-Kent Publishing; 1990.
32. Nothnick WB. Tissue inhibitor of metalloproteinase-1 (TIMP-1) deficient mice display reduced serum progesterone levels during corpus luteum development. Endocrinology 2003; 144:5-8.
33. Kirkland JL, Gardner RN, Ireland JS, Stancel GM. The effect of hypophysectomy on the uterine response to estradiol. Endocrinology 1977; 101:403-410.
34. Harris J, Gorski J. Evidence for a discontinuous requirement for estrogen in stimulation of deoxyribonucleic acid synthesis in the immature rat uterus. Endocrinology 1978; 103:204-245.
35. Rockwell LC, Pillai S, Olson CE, Koos RD. Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 2002; 67:1804-1810.
36. Hastings JM, Licence DR, Burton GJ, Charnock-Jones DS, Smith SK. Soluble vascular endothelial growth factor receptor 1 inhibits edema and epithelial proliferation induced by 17β-estradiol in the mouse uterus. Endocrinology 2003; 144:326-334.
37. Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells. Role of flt-1. Circ Res 1998; 83:832-840.
38. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153:557-562.
39. Partridge CA, Jeffrey JJ, Malik AB. A 96-kDa gelatinase induced by TNF-α contributes to increased microvascular endothelial permeability. Am J Physiol 1993; 265:438-447.
40. Zucker S, Mirza H, Conner CE, Lorenz AI, Drews MH, Bahov WF, Jesty J. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998; 75:780-786.
41. Truss M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 1993; 14:459-479.
42. Wakeling AE, Dules M, Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res 1991; 51:3867-3873.
43. Clark JH, Mani SK. Actions of steroid hormone receptors. In Knobil E, Neill J (eds.), The Physiology of Reproduction. New York: Raven Press; 1994:1011-1059.
44. Revelli A, Massobrio M, Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev 1998; 19:3-17.
45. 2+ entry in human endometrial cells. Mol Cell Endocrinol 2001; 176:77-84.
46. Ishii K, Kano T, Ando J. Calcium channel, Ca++ mobilization, and mechanical reactivity of estrogen- and progesterone-treated rat uterus. Jpn J Pharmacol 1986; 41:47-54.
47. Batra S. Increase by oestrogen of calcium entry and calcium channel density in uterine smooth muscle. Br J Pharmacol 1987; 92:389-392.
48. Kohn EC, Jacobs W, Kim YS, Alessandro R, Stetler-Stevenson WG, Liotta LA. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). J Biol Chem 1994; 269:21505-21511.
49. Lohi J, Keski-Oja J. Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation. J Biol Chem 1995; 270:17602-17609.
50. Kobayashi T, Hattori S, Nagai Y, Tajima S, Nishikawa T. Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes. Dermatology 1998; 197:1-5.
51. Conant K, Haughey N, Nath A, St Hillaire C, Gary DS, Pardo CA, Wahl LM, Bilak M, Milward E, Mattson MP. Matrix metalloproteinase-1 activates a pertussis toxin-sensitive signaling pathway that stimulates the release of matrix metalloproteinase-9. J Neurochem 2002; 82:885-893.
52. Smith CL. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod 1998; 58:627-632.
53. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17:463-516.
54. Fowlkes JL, Winkler MK. Exploring the interface between metalloproteinase activity and growth factor and cytokine bioavailability. Cytokine Growth Factor Rev 2002; 13:277-287.